Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OSI raises $387 million

OSIP raised $387 million in a bumped-up follow-on through the sale

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE